• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

President applauds low-cost CAR T-cell Cancer Therapy

Raja Aditya by Raja Aditya
3 years ago
in Research & Development, Science News
0
CAR T-cell

President Droupadi Murmu with Maharashtra Governor Ramesh Bais, IIT Bombay Director Subhasis Chaudhuri, Tata Memorial Centre Director Sudeep Gupta and others during the launch of the first indigenous CAR-T cell therapy, in Mumbai. Image Credits: Google

India’s first domestically created CAR T-cell therapy was introduced by President Droupadi Murmu, who hailed the development as a significant advancement that offers “new hope for humankind” in the fight against the illness. According to a senior official, gene-based treatment, developed by the Indian Institute of Technology (IIT) Bombay and Tata Memorial Centre, is being introduced in India at a cost that is around 10% of what it costs outside.

Speaking at the therapy’s debut event at IIT Bombay, Murmu cited the therapy’s indigenous creation as an illustration of the Made in India campaign. Through laboratory modification, a patient’s T cells—a subset of immune system cells—is used in a CAR T-cell treatment to target and eliminate cancer cells. The nation’s first “Made in India” CAR T-cell therapy, called “NexCAR19 CAR T-cell therapy,” is anticipated to drastically reduce treatment costs. The president stated in her address that this therapy is regarded as a fantastic advancement in the medical sciences.

“The development of this therapy is also an example of the ‘Make in India‘ initiative and speaks volumes about Indian scientists and physicians,” she stated.

“The introduction of the first gene treatment in India represents a significant advance in the fight against cancer. CAR T-cell therapy represents a new hope for humanity as a whole since it is an accessible and cost-effective therapeutic option, according to Murmu. The majority of patients cannot afford the prohibitively costly CAR T-cell treatment, according to Sudeep Gupta, director of the Tata Memorial Centre.

Despite the fact that NexCar19 must be specially made for each patient under the strictest guidelines, he said that it has been released for around tenth of the cost of what it costs outside of India. According to Prof. Subhasis Chaudhuri, director of IIT Bombay, the cost of therapy overseas is about Rs. 4 crore, compared to Rs. 30 lakh in India. According to him, the availability of low-cost CAR T-cell treatment is a major victory for the nation and cancer patients, solidifying India’s position as a leader in gene and cell therapy worldwide.

“Just like Chandrayaan-3 that launched India’s entry into elite space club, the CAR-T cell therapy heralds India’s entry into the cell and genetic engineering group,” said Chaudhuri. According to Gupta, the medication’s introduction marks a turning point in the fields of genetic engineering and cancer treatment, helping about 20,000 Indians annually. “This therapy has a wide range of practical applications in addition to being a top-notch scientific discovery. He declared, “NexCAR19 will wipe many, many tears and save many, many lives.”

-Raja Aditya

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: CAR T-cell Cancer TherapyDroupadi MurmufeaturedInstitute of Technology (IIT) BombayMade in IndiaNexCAR19sciencenewsTata Memorial Centre
Raja Aditya

Raja Aditya

Associate Editor for Neo Science Hub Magazine

Other Posts

If Machines Do the Work, What Is Left for Us?

If Machines Do the Work, What Is Left for Us?

November 22, 2026
0
Bar chart of decreasing bars beside a line-art antibiotic icon

When the Last Antibiotic Fails: ICMR Finds 91 Per Cent Carbapenem Resistance in a Common Hospital Pathogen

November 21, 2026
5

Akvan Turns North and Drops a Category: IMD Now Expects a Severe Cyclone Between Narsapur and Puri, While Andhra’s Own Forecasters Expect Less

Antalya’s Last Forty-Eight Hours: Two Contradictory Paragraphs on Fossil Fuels, and India’s Line on the Carbon Budget

Disarm, Don’t Kill: CCMB Scientists Find Two Compounds That Stop a Deadly Fungus Turning Invasive

Eighty Per Cent of the Cost: Andhra Pradesh Raises the Stakes in India’s Chip-Subsidy Contest

Before the First Breath: UNEP and WHO Say Hormone-Disrupting Chemicals Reach Us in the Womb

The Morning Eye Closes: NASA Will Switch Off Terra After 27 Years of Watching the Planet

Next Post
IIM Lucknow Study Reveals Agtech Platforms' Role in Digitizing Indian Agriculture

IIM Lucknow Study Reveals Agtech Platforms' Role in Digitizing Indian Agriculture

Please login to join discussion

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
11

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist